CT Guided Percutaneous Vertebroplasty for Vertebral Non-union Following Posterior Fixation

October 7, 2021 updated by: Centre Hospitalier Universitaire de Nice

A Retrospectice Evaluation of the Feasibility and Usefulness of a Percutaneous Vertebroplasty Performed on Patients Treated With Posterior Fixation Suffering Non-union After a Traumatic Non-neurologic Vertebral Fracture

Traumatic thoracolumbar vertebral fractures are frequently treated with posterior fixation (PF) and vertebral augmentation, but sometimes vertebral augmentation is not performed, being judged too risky under fluoroscopic guidance alone. An adjuvant CT/fluoroscopy guided percutaneous vertebroplasty (PVP) could be an option.

The aim was to evaluate feasibility, safety and effectiveness of PVP in patients with vertebral non-union (VNU) following PF performed without concomitant vertebral augmentation.

All patients treated in our institution with PVP between July 2015-July 2020 were retrospectively reviewed. Patients treated with CT/fluoroscopy guided PVP under local anesthesia for symptomatic VNU following PF were selected. Three criteria were established to assess cement distribution, considering vertebral filling of: 1)fracture cleft, 2)anterior two-thirds of the vertebral body, 3)from superior to inferior endplates. Numeric pain rating scale (NPRS) assessing grade of discomfort (0=no pain; 10=worst pain) and complications were evaluated before and one month after PVP.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nice, France, 06200
        • CHU de Nice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients treated with a percutaneous vertebroplasty in our centre between 01/07/2015 and 01/07/2020 under combined CT/fluoroscopy guidance

Description

Inclusion Criteria:

  • PVP performed between July 2015-July 2020 under combined CT and fluoroscopy guidance;
  • Previous PF for traumatic non-neurological thoracolumbar vertebral fracture;
  • Imaging evidence of vertebral non-union;
  • Pain and functional impairment persisting for more at least one month after PF;
  • Informed patient consent for PVP procedure under CT and fluoroscopy guidance;
  • Previous multidisciplinary case discussion between spine surgeons and interventional radiologists.

Exclusion Criteria:

  • Age inferior to 18 years old
  • Absence of complications due to orthopaedic hardware;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of the procedure assessing consolidation and pain reduction 1 month after percutaneous vertebroplasty
Time Frame: 18 months
Numeric Pain Rate Scale (from 0 to 10 points, where 0 no pain, 10 maximum pain)
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technical success of the percutaneous vertebroplasty
Time Frame: 18 months
criteria of cement filling rate of vertebral body established by the authors
18 months
Safety of the procedure
Time Frame: 18 months
Complication rate during and after the procedure using CIRSE adverse event reports
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2019

Primary Completion (Actual)

July 1, 2020

Study Completion (Actual)

September 15, 2021

Study Registration Dates

First Submitted

September 28, 2021

First Submitted That Met QC Criteria

October 7, 2021

First Posted (Actual)

October 8, 2021

Study Record Updates

Last Update Posted (Actual)

October 8, 2021

Last Update Submitted That Met QC Criteria

October 7, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 21Imagerie02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

no data sharing plan has been established

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vertebral Fracture

Clinical Trials on percutaneous vertebroplasty

Subscribe